Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
Open Access
Abstract
Rationale Nasal allergen provocations may be useful in investigating the pathophysiology of allergic rhinitis and effects of treatments. Objective To use grass pollen nasal allergen challenge (NAC) to investigate the effects of allergen immunotherapy in a cross‐sectional study. Methods We studied nasal and cutaneous responses in untreated subjects with seasonal grass‐pollen allergic rhinitis (n = 14) compared with immunotherapy‐treated allergics (n = 14), plus a nonatopic control group (n = 14). Volunteers underwent a standardized NAC with 2000 biological units of timothy grass allergen (equivalent to 1.3 μg major allergen, Phl p5). Nasal fluid was collected and analysed by ImmunoCAP and multiplex assays. Clinical response was assessed by symptom scores and peak nasal inspiratory flow (PNIF). Cutaneous response was measured by intradermal allergen injection. Retrospective seasonal symptom questionnaires were also completed. Results Immunotherapy‐treated patients had lower symptom scores (P = 0.04) and higher PNIF (P = 0.02) after challenge than untreated allergics. They had reduced early (P = 0.0007) and late (P < 0.0001) skin responses, and lower retrospective seasonal symptom scores (P < 0.0001). Compared to untreated allergics, immunotherapy‐treated patients had reduced nasal fluid concentrations of IL‐4, IL‐9 and eotaxin (all P < 0.05, 8 h level and/or area under the curve comparison), and trends for reduced IL‐13 (P = 0.07, area under the curve) and early‐phase tryptase levels (P = 0.06). Conclusions Nasal allergen challenge is sensitive in the detection of clinical and biological effects of allergen immunotherapy and may be a useful surrogate marker of treatment efficacy in future studies.Keywords
Funding Information
- Wellcome Trust (WHRA_P39653)
- ALK Abello
- Immune Tolerance Network (NIH Contract #N01 AI15416)
This publication has 30 references indexed in Scilit:
- Aberrant dendritic cell function conditions Th2‐cell polarization in allergic rhinitisAllergy, 2013
- Can Immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen?Clinical & Experimental Allergy, 2011
- The economic impact of allergic rhinitis and current guidelines for treatmentAnnals of Allergy, Asthma & Immunology, 2011
- Mediators and cytokines in allergic and viral-triggered rhinitisAllergy and Asthma Proceedings, 2007
- Topical corticosteroid inhibits interleukin‐4, ‐5 and ‐13 in nasal secretions following allergen challengeClinical & Experimental Allergy, 2005
- The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challengeAllergy, 2005
- IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapyJournal of Allergy and Clinical Immunology, 2005
- Correlations between Complaints, Inflammatory Cells and Mediator Concentrations in Nasal Secretions after Nasal Allergen Challenge and during Natural Allergen ExposureInternational Archives of Allergy and Immunology, 1995
- Responses to ragweed-pollen nasal challenge before and after immunotherapyJournal of Allergy and Clinical Immunology, 1989
- Nasal challenge with pollen grains, skin‐prick tests and specific IgE in patients with grass pollen allergyClinical & Experimental Allergy, 1987